Skip to main content

Peer Review reports

From: Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial

Original Submission
4 Mar 2024 Submitted Original manuscript
12 Mar 2024 Author responded Author comments - Chun Han
25 Mar 2024 Author responded Author comments - Chun Han
Resubmission - Version 2
12 Mar 2024 Submitted Manuscript version 2
29 Mar 2024 Author responded Author comments - Chun Han
Resubmission - Version 3
29 Mar 2024 Submitted Manuscript version 3
25 Apr 2024 Reviewed Reviewer Report
1 May 2024 Reviewed Reviewer Report
13 May 2024 Author responded Author comments - Chun Han
Resubmission - Version 4
13 May 2024 Submitted Manuscript version 4
22 May 2024 Reviewed Reviewer Report
22 May 2024 Reviewed Reviewer Report - Jun Itami
23 May 2024 Author responded Author comments - Chun Han
Resubmission - Version 5
23 May 2024 Submitted Manuscript version 5
Publishing
24 May 2024 Editorially accepted
4 Jun 2024 Article published 10.1186/s12885-024-12427-y

You can find further information about peer review here.

Back to article page